Preview

Modern Rheumatology Journal

Advanced search

Takayasu arteritis in children and adults: epidemiological data, clinical manifestations, survival, and mortality

https://doi.org/10.14412/1996-7012-2026-2-108-114

Abstract

The prevalence of Takayasu arteritis (TA), its clinical presentation, and survival rates may vary among patients depending on age at disease onset and region of residence. The origin of this heterogeneity has not been fully elucidated; pathogenetic mechanisms are associated with genetic, autoimmune, and infectious factors. Nonspecific and heterogeneous symptoms lead to delayed diagnosis and the development of ischemic complications. This article presents a review of publications addressing the characteristics of TA across different age and ethnic groups.

About the Authors

A. M. Bolotbekova
National Center of Cardiology and Therapy named after Academician Mirsaid Mirrakhimov under the Ministry of Health of the Kyrgyz Republic
Kyrgyzstan

Altynai Maratovna Bolotbekova 

3, Togolok Moldo Street, Bishkek 720040 



G. M. Koilubaeva
National Center of Cardiology and Therapy named after Academician Mirsaid Mirrakhimov under the Ministry of Health of the Kyrgyz Republic
Kyrgyzstan

3, Togolok Moldo Street, Bishkek 720040 



O. N. Egorova
V.A. Nasonova Research Institute of Rheumatology ; M.F. Vladimirsky Moscow Regional Research Clinical Institute
Russian Federation

34A, Kashirskoe Shosse, Moscow 115522 

61/2, Shchepkina Street, Moscow 129110, Moscow 



I. A. Guseva
V.A. Nasonova Research Institute of Rheumatology
Russian Federation

34A, Kashirskoe Shosse, Moscow 115522 



A. A. Okunova
National Center of Cardiology and Therapy named after Academician Mirsaid Mirrakhimov under the Ministry of Health of the Kyrgyz Republic
Kyrgyzstan

3, Togolok Moldo Street, Bishkek 720040 



G. M. Tarasova
V.A. Nasonova Research Institute of Rheumatology
Russian Federation

34A, Kashirskoe Shosse, Moscow 115522 



A. O. Abdykerimov
National Center of Cardiology and Therapy named after Academician Mirsaid Mirrakhimov under the Ministry of Health of the Kyrgyz Republic
Kyrgyzstan

3, Togolok Moldo Street, Bishkek 720040 



Sh. P. Ashuraliev
National Center of Cardiology and Therapy named after Academician Mirsaid Mirrakhimov under the Ministry of Health of the Kyrgyz Republic
Kyrgyzstan

3, Togolok Moldo Street, Bishkek 720040 



References

1. Wahren-Herlenius M, Dorner T. Immunopathogenetic mechanisms of systemic autoimmune diseases. Lancet. 2013 Aug 31; 382(9894):819-31. doi: 10.1016/S0140-6736(13)60954-X.

2. Mason J. Takayasu’s arteritis – advances in diagnosis and management. Nat Rev Rheumatol. 2010 Jul;6(7):406-15. doi: 10.1038/nrrheum.2010.82.

3. Grabovyi DA, Dzhinibalaeva ZhV, Adonina EV, Duplyakov DV. Takayasu arteritis in a patient with suspected acute coronary syndrome — literature review and clinical case. Rossiiskii kardiologicheskii zhurnal. 2021;26(1S):4345. (In Russ.).

4. Abacar K, Macleod T, Direskeneli H, McGonagle D. Takayasu arteritis: a geographically distant but immunologically proximal MHC-I-opathy. Lancet Rheumatol. 2025 Apr; 7(4):e290-e302. doi: 10.1016/S2665-9913(24)00307-2.

5. Yajima M, Moriwaki R, Numano F, et al. Comparative studies between Japanese and Korean patients: comparison of the findings of angiography, HLA-Bw52, and clinical manifestations. Heart Vessels Suppl. 1992:7:102-5. doi: 10.1007/BF01744553.

6. Saadoun D, Garrido M, Comarmond C, et al. Th1 and Th17 cytokines drive inflammation in Takayasu's arteritis. Arthritis Rheumatol. 2015 May;67(5):1353-60. doi: 10.1002/art.39037.

7. Saruhan-Direskeneli G, Hughes T, Aksu K, et al. Identification of multiple genetic susceptibility loci in Takayasu arteritis. Am J Hum Genet. 2013 Aug 8;93(2):298-305. doi: 10.1016/j.ajhg.2013.05.026.

8. Tamura Т, Mejia Y, Matsumura Е, et al. Single-Nucleotide Polymorphism of the MLX Gene Is Associated with Takayasu’s Arteritis. Circ Genom Precis Med. 2018 Oct;11(10): e002296. doi: 10.1161/CIRCGEN.118.002296.

9. Onen F, Akkoc N. Epidemiology of Takayasu’s arteritis. Presse Med. 2017 JulAug;46(7-8 Pt 2):e197-e203. doi: 10.1016/j.lpm.2017.05.034.

10. Mossberg M, Segelmark M, Kahn R, at al. Epidemiology of primary systemic vasculitis in children: a population-based study from southern Sweden. Scand J Rheumatol. 2018 Jul;47(4):295-302. doi: 10.1080/03009742.2017.1412497.

11. Jang SY, Seo SR, Park SW, Kim DK. Prevalence of Takayasu’s arteritis in Korea. Clin Exp Rheumatol. 2018 Mar-Apr;36 Suppl 111(2):163-164.

12. Sun Y, Yin MM, Ma LL, et al. Epidemiology of Takayasu arteritis in Shanghai: A hospital-based study and systematic review. Int J Rheum Dis. 2021 Oct;24(10):1247-1256. doi: 10.1111/1756-185X.14183.

13. Feng Y, Tang X, Liu M, et al. Clinical study of children with Takayasu arteritis: a retrospective study from a single center in China. Pediatr Rheumatol Online J. 2017 Apr 17; 15(1):29. doi: 10.1186/s12969-017-0164-2.

14. Mustafa KN. Takayasu’s arteritis in Arabs. Clin Rheumatol. 2014 Dec;33(12):1777-83. doi: 10.1007/s10067-014-2633-z.

15. el-Reshaid K, Varro J, al-Duwairi Q, Anim JT. Takayasu's arteritis in Kuwait. J Trop Med Hyg. 1995 Oct;98(5):299-305.

16. Birlik M, Kucukyavas Y, Aksu K, et al. Epidemiology of Takayasu’s arteritis in Turkey. Clin Exp Rheumatol. 2016;34:S33-39.

17. Pagoaga-Vasquez DP, Melendez-Ramirez G, Patiсo-Bahena EJ, et al. Clinical profile and long-term outcomes of pediatric-onset Takayasu's arteritis: data from a mexican national referral center. Pediatr Rheumatol Online J. 2025 Oct 21;23(1):106. doi: 10.1186/s12969-025-01145-9.

18. Hong CY, Yun YS, Choi JY, et al. Takayasu’s arteritis in Korean children: clinical report of seventy cases. Heart Vessels Suppl. 1992:7:91-6. doi: 10.1007/BF01744551.

19. Szugye HS, Zeft AS, Spalding SJ. Takayasu’s Arteritis in the pediatric population: a contemporary United States-based single center cohort. Pediatr Rheumatol Online J. 2014 Jun 4:12:21. doi: 10.1186/1546-0096-12-21.

20. Cakar N, Yalcinkaya F, Duzova A, et al. Takayasu’s arteritis in children. J Rheumatol. 2008 May;35(5):913-9.

21. Hassold N, Dusser P, Laurent A, et al. Clinical spectrum and outcome of Takayasu's arteritis in children. Joint Bone Spine. 2024 Sep;91(5):105735. doi: 10.1016/j.jbspin.2024.105735.

22. Goel R, Kumar TS, Danda D, et al. Childhood-onset Takayasu’s arteritis – experience from a tertiary care center in South India. J Rheumatol. 2014 Jun;41(6):1183-9. doi: 10.3899/jrheum.131117.

23. Hahn D, Thomson PD, Kala U, et al. A review of Takayasu's arteritis in children in Gauteng, South Africa. Pediatr Nephrol. 1998 Oct;12(8):668-75. doi: 10.1007/s004670050526.

24. Soto ME, Espinola N, Flores-Suarez LF, et al. Takayasu arteritis: clinical features in 110 Mexican Mestizo patients and cardiovascular impact on survival and prognosis. Clin Exp Rheumatol. 2008 May-Jun;26(3 Suppl 49): S53-6.

25. Ishikawa K. Natural history and classification of occlusive thromboaortopathy (Takayasu’s disease). Circulation. 1978 Jan; 57(1): 27-35. doi: 10.1161/01.cir.57.1.27.

26. Park MC, Lee SW, Park YB, et al. Clinical characteristics and outcomes of Takayasu’s arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment, and angiographic classification. Scand J Rheumatol. 2005 Jul-Aug;34(4):284-92. doi: 10.1080/03009740510026526.

27. Comarmond C, Biard L, Lambert M, et al. Long-term outcomes and prognostic factors of complications in Takayasu arteritis: a multicenter study of 318 patients. Circulation. 2017 Sep 19;136(12):1114-1122. doi: 10.1161/CIRCULATIONAHA.116.027094.

28. Piyachon C, Suwanwela N. Takayasu’s arteritis in Thailand. Heart Vessels Suppl. 1992:7:60-7. doi: 10.1007/BF01744546.

29. Hata A, Noda M, Moriwaki R, Numano F. Angiographic findings of Takayasu arteritis: new classification. Int J Cardiol. 1996 Aug;54 Suppl:S155-63. doi: 10.1016/s0167-5273(96)02813-6.

30. Sharma BK, Sagar S, Singh AP, Suri S. Takayasu’s arteritis in India. Heart Vessels Suppl. 1992;7:37-43. https://doi.org/10.1007/BF01744542.

31. Dreyer L, Faurschou M, Baslund B. A population-based study of Takayasu's arteritis in eastern Denmark. Clin Exp Rheumatol. Jan-Feb 2011;29(1 Suppl 64):S40-2.

32. Karageorgaki Z, Bertsias GK, Mavragani CP, et al. Takayasu’s arteritis: epidemiological, clinical, and immunogenetic features in Greece. Clin Exp Rheumatol. 2009 Jan-Feb; 27(1 Suppl 52):S33-9.

33. Muranjan MN, Bavdekar SB, More V, et al. Study of Takayasu's arteritis in children: clinical profile and management. J Postgrad Med. 2000 Jan-Mar;46(1):3-8.

34. Sahin S, Hopurcuoglu D, Bektas S, et al. Childhood-onset Takayasu’s arteritis: A 15-year experience from a tertiary referral center. Int J Rheum Dis. 2019 Jan;22(1): 132-139. doi: 10.1111/1756-185X.13425.

35. Eleftheriou D, Varnier G, Dolezalova P, et al. Takayasu arteritis in childhood: retrospective experience from a tertiary referral centre in the United Kingdom. Arthritis Res Ther. 2015 Feb 25;17(1):36. doi: 10.1186/s13075-015-0545-1.

36. Terreri MT, Clemente G, Oliveira SK, et al. Brazilian multicentre study of Takayasu’s arteritis in children and adolescents – preliminary results of a clinical, imaging and therapeutic study. Pediatr Rheumatol. 2011 Sep; 9 (Suppl 1):P89. doi: 10.1186/1546-0096-9-S1-P89.

37. Terao C. Revisited HLA and non-HLA genetics of Takayasu arteritis – where are we? J Hum Genet. 2016 Jan;61(1):27-32. doi: 10.1038/jhg.2015.87.

38. Mason JC. Surgical intervention and its role in Takayasu’s arteritis. Best Pract Res Clin Rheumatol. 2018 Feb;32(1):112-124. doi: 10.1016/j.berh.2018.07.008.

39. Fan L, Zhang H, Cai J, et al. Clinical course and prognostic factors of childhood Takayasu’s arteritis: over 15-year comprehensive analysis of 101 patients. Arthritis Res Ther. 2019 Jan 22;21(1):31. doi: 10.1186/s13075-018-1790-x.

40. Saeed T, Terreri MT, Sacchetti SB, et al. Takayasu arteritis in children and adolescents: a Latin American multicenter collaboration study of 55 patients. Pediatr Rheumatol Online J. 2018;16(1):55. doi:10.1186/s12969-018-0271-1.

41. https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-takayasuarteritis.

42. Clemente G, Hilario MO, Lederman H, et al. Takayasu arteritis in a Brazilian multicenter study: children with a longer diagnosis delay than adolescents. Clin Exp Rheumatol. 2014 May-Jun;32(3 Suppl 82):S128-33.

43. Chikhladze NM. Arterial hypertension in patients with aortoarteritis. Sistemnye gipertenzii. 2018;15(2):43-48. (In Russ.).

44. Flynn JT, Kaelber DC, Baker-Smith CM, et al. Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. Pediatrics. 2017 Sep;140(3):e20171904. doi: 10.1542/peds.2017-1904.

45. Watanabe Y, Miyata T, Tanemoto K. Current Clinical Features of New Patients with Takayasu Arteritis observed from Cross-Country research in Japan: age and sex Specificity. Circulation. 2015 Nov 3;132(18):1701-9. doi: 10.1161/CIRCULATIONAHA.114.012547.

46. Smitienko IO. Clinical variants of organ lesions, assessment of activity and prognosis of Takayasu arteritis. Autoref. diss. cand. med. sci. Moscow; 2010.

47. Borodina IE. Takayasu's arteritis. Training manual. Ekaterinburg: UGMU; 2022.

48. Danda D, Goel R, Joseph G, et al. Clinical course of 602 patients with Takayasu's arteritis: comparison between Childhood-onset versus adult onset disease. Rheumatology (Oxford). 2021 May;60(5):2246–2255. doi: 10.1093/rheumatology/keaa569.

49. Kang EJ, Kim SM, Choe YH, et al. Takayasu Arteritis: Assessment of Coronary Arterial Abnormalities with 128-Section Dual-Source CT Angiography of the Coronary Arteries and Aorta. Radiology. 2014 Jan;270(1):74-81. doi: 10.1148/radiol.13122195.

50. Sun T, Zhang H, Ma W, et al. Coronary artery involvement in Takayasu arteritis in 45 Chinese patients. J Rheumatol. 2013 Apr; 40(4):493-7. doi: 10.3899/jrheum.120813.

51. Wilson L, Chandran A, Fudge JC, et al. Takayasu’s arteritis presenting as acute myocardial infarction: case series and literature review. Cardiol Young. 2021 Nov;31(11):1866- 1869. doi: 10.1017/S1047951121001700.

52. Lei C, Huang Y, Yuan S, et al. Takayasu Arteritis with coronary artery Involvement: differences between pediatric and adult patients. Can J Cardiol. 2020 Apr;36(4):535-542. doi: 10.1016/j.cjca.2019.08.039.

53. Brunner J, Feldman BM, Tyrrell PN, et al. Takayasu’s arteritis in children and adolescents. Rheumatology (Oxford). 2010 Oct; 49(10):1806-14. doi: 10.1093/rheumatology/keq167.

54. Ahn SS, Han M, Park YB, et al. Incidence, prevalence and risk of stroke in patients with Takayasu arteritis: a nationwide population-based study in South Korea. Stroke Vasc Neurol. 2022 Apr;7(2):149-157. doi: 10.1136/svn-2020-000809.

55. Yang L, Zhang H, Jiang X, et al. Clinical manifestations and longterm outcome for patients with Takayasu arteritis in China. J Rheumatol. 2014 Dec;41(12):2439-46. doi: 10.3899/jrheum.140664.

56. Mirouse A, Biard L, Comarmond C, et al. Overall survival and mortality risk factors in Takayasu's arteritis: a multicenter study of 318 patients. J Autoimmun. 2019 Jan:96:35-39. doi: 10.1016/j.jaut.2018.08.001.

57. Jang SY, Park TK, Kim DK. Survival and causes of death for Takayasu's arteritis in Korea: a retrospective population-based study. Int J Rheum Dis. 2021 Jan;24(1):69-73. doi: 10.1111/1756-185X.14005.

58. Borodina IE, Popov AA, Shardina LA. The effect of late diagnosis on survival and risk of vascular complications in patients with Takayasu arteritis. Nauchno-prakticheskaya revmatologiya. 2021;59(6):720-726. (In Russ.).

59. Shi X, Du J, Li T. Risk factors and surgical prognosis in patients with aortic valve involvement caused by Takayasu arteritis Shi et al. Arthritis Res Ther. 2022 May 7;24(1):102. doi: 10.1186/s13075-022-02788-9.

60. Aeschlimann FA, Eng SWM, Sheikh S, et al. Childhood Takayasu arteritis: disease course and response to therapy. Arthritis Res Ther. 2017 Nov 22;19(1):255. doi: 10.1186/s13075-017-1452-4.

61. He S, Li R, Jin S, et al. Predictors of relapse in Takayasu arteritis. Eur J Intern Med. 2023 May:111:105-112. doi: 10.1016/j.ejim.2023.02.027.


Review

For citations:


Bolotbekova AM, Koilubaeva GM, Egorova ON, Guseva IA, Okunova AA, Tarasova GM, Abdykerimov AO, Ashuraliev SP. Takayasu arteritis in children and adults: epidemiological data, clinical manifestations, survival, and mortality. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2026;20(2):108-114. (In Russ.) https://doi.org/10.14412/1996-7012-2026-2-108-114

Views: 421

JATS XML


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1996-7012 (Print)
ISSN 2310-158X (Online)